- Home
- CNDT vs TARA Comparison
CNDT vs TARA Comparison
Compare CNDT & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNDT | TARA |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | 51000 | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 268.5M |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CNDT | TARA |
|---|---|---|
| Price | $1.29 | $5.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.67 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,042,000,000.00 | $2,948,000.00 |
| Revenue This Year | $1.81 | N/A |
| Revenue Next Year | $4.26 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.18 | $2.77 |
| 52 Week High | $3.19 | $7.82 |
Technical Indicators
Market Signals| Indicator | CNDT | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 38.55 | 38.85 |
| Support Level | $1.18 | $5.02 |
| Resistance Level | $1.60 | $5.77 |
| Average True Range (ATR) | 0.09 | 0.46 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 16.87 | 2.96 |
Price Performance
Historical ComparisonAbout CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).